Sound Pharmaceuticals Obtains $3,800,000 New Financing Round

  • Feed Type
  • Date
    9/19/2016
  • Company Name
    Sound Pharmaceuticals
  • Mailing Address
    4010 Stone Way N Seattle, WA 98103 USA
  • Company Description
    Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
  • Website
    http://www.soundpharmaceuticals.com
  • Transaction Type
    Debt
  • Transaction Amount
    $3,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy